Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus

BACKGROUND/AIMS: This study aimed to predict sustained viral response (SVR) to low-dose pegylated interferon (PEG-IFN) plus ribavirin of elderly and/or cirrhotic patients with genotype 2 hepatitis C virus (HCV) using viral response within 2 weeks. METHODS: Low-dose PEG-IFN-α-2b plus ribavirin was ad...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Gut Liver
Main Authors: Tamai, Hideyuki, Shingaki, Naoki, Mori, Yoshiyuki, Moribata, Kosaku, Kawashima, Akira, Maeda, Yoshimasa, Niwa, Toru, Deguchi, Hisanobu, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Kato, Jun, Ichinose, Masao
Formato: Artigo
Idioma:Inglês
Publicado: Editorial Office of Gut and Liver 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933424/
https://ncbi.nlm.nih.gov/pubmed/26601828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15193
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares